论文部分内容阅读
通过比较α-干扰素治疗慢性乙型肝炎的费用和收益,从经济方面分析在我国这种治疗的意义.结果表明这种治疗不仅可拯救生命、延长病人的存活时间,而且可大大改善病人的生活质量.在经济方面,用α-干扰素治疗慢性乙型肝炎的成本效益比值(干扰素的治疗费用/因治疗而节省的费用)为1.22,即每投入1元可节省医疗费用1.22元;若同时计算因病休损失的社会费用,成本效益比值为3.02,平均每年为社会减少大量的由肝病导致的经济损失.提示在上海地区用α-干扰素治疗慢性乙型肝炎病人具有重要的医学和经济意义.
By comparing the costs and benefits of interferon-alpha in the treatment of chronic hepatitis B, we analyze the significance of this treatment in our country from an economic point of view.The results show that this treatment can not only save lives, prolong the survival time of patients, but also greatly improve the patient’s In economic terms, the cost-benefit ratio of interferon-alpha for the treatment of chronic hepatitis B (the cost of interferon treatment / cost savings from treatment) is 1.22, which means that for every 1 yuan invested, the medical cost of 1.22 yuan can be saved; If we calculate the cost of social loss due to sickness at the same time, the cost-benefit ratio is 3.02, which will reduce the social loss caused by liver disease on average every year.It is suggested that the treatment of chronic hepatitis B patients with interferon-alpha in Shanghai has important medical and Economic significance.